PubMed Central (PMC) Search Page
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 1998 | 1 |
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 4 |
| 2004 | 4 |
| 2005 | 9 |
| 2006 | 4 |
| 2007 | 4 |
| 2008 | 37 |
| 2009 | 54 |
| 2010 | 63 |
| 2011 | 82 |
| 2012 | 84 |
| 2013 | 69 |
| 2014 | 78 |
| 2015 | 58 |
| 2016 | 59 |
| 2017 | 36 |
| 2018 | 60 |
| 2019 | 43 |
| 2020 | 67 |
| 2021 | 40 |
| 2022 | 49 |
| 2023 | 41 |
| 2024 | 30 |
| 2025 | 15 |
| 2026 | 7 |
-
Publication date
-
-
Publication stage
These filters represent the three primary types of content included in the PMC archive: 1) content published in a scholarly journal 2) peer-reviewed author manuscripts accepted for publication in a journal and 3) preprint versions of articles collected through the NIH Preprint Pilot, made public prior to peer review
-
-
Collections
The PMC Open Access Subset includes journal articles and preprints that are made available under license terms that allow reuse. Historical back issues refers to digitized content from print journals made available in PMC through the Biomedical Journal Digitization Projects.
-
"Hum Gene Ther"[Journal]
The embargo is the time during which the publisher retains exclusive rights to distribute articles. Those articles are made freely available on the PMC website after the embargo period has ended. Citations for articles under an embargo period will still display in the PMC results list by default. Choose “Exclude” to prevent embargoed articles from displaying in your results.
-
Enhancing AAV9-UFμDys1 Gene Therapy Efficacy Through Immunosuppression in Mice with Pre-Existing Immunity and Enabling Redosing Strategies for Duchenne Muscular Dystrophy.
- Saha M, Bhake R, Meyers CA, Coleman K, Trivedi PD, Gallman M, Biswas M, Herzog RW, Byrne BJ, Corti M.
- Hum Gene Ther. 2025 Oct 13;37(1-2):17-32. doi: 10.1177/10430342251385586.
- PMCID: PMC13548098
Saha M, et al.Hum Gene Ther. 2025.PMCID: PMC13548098 -
Update on Gene Therapy Clinical Trials for Eye Diseases.
- Lonfat N, Moreno-Leon L, Punzo C, Khanna H.
- Hum Gene Ther. 2025 Sep 18;36(19-20):1287-1300. doi: 10.1177/10430342251379824.
- PMCID: PMC13089423
Lonfat N, et al.Hum Gene Ther. 2025.PMCID: PMC13089423 -
A Comprehensive Review of Clinically Applied Adeno-Associated Virus-Based Gene Therapies for Ocular Disease.
- Hinsch VG, Boye SL, Boye SE.
- Hum Gene Ther. 2025 Feb 24;36(19-20):1301-1320. doi: 10.1089/hum.2024.252.
- PMCID: PMC13089426
Hinsch VG, et al.Hum Gene Ther. 2025.PMCID: PMC13089426 -
A Tripartite AAV System with Engineered Lox Sites Enables Efficient Delivery of the EYS Gene for Retinal Gene Therapy.
- Rhee KD, Datta P, Baccam C, Seo S.
- Hum Gene Ther. Author manuscript. 2026 Feb 19;37(9-10):442-452. doi: 10.1177/10430342261426597.
- PMCID: PMC13592567
Rhee KD, et al.Hum Gene Ther. Author manuscript. 2026.PMCID: PMC13592567 -
Deep Intronic SVA_E Retrotransposition as a Novel Factor in Canavan Disease Pathogenesis.
- Weiß M, Selig M, Friedrich J, Wierczeiko A, Diederich S, Sigel H, Bredow J, Eichler FS, Nagy A, Seyler D, Holthöfer L, Gerber S, Schweiger S, Linke M, Bley A.
- Hum Gene Ther. 2025 Apr 21;36(17-18):1248-1256. doi: 10.1089/hum.2025.006.
- PMCID: PMC12596875
Weiß M, et al.Hum Gene Ther. 2025.PMCID: PMC12596875 -
Recombinant Adeno-Associated Virus Vector Mediated Gene Editing in Proliferating and Polarized Cultures of Human Airway Epithelial Cells.
- Park SY, Feng Z, Choi SH, Zhang X, Tang Y, Gasser GN, Richart D, Yuan F, Qiu J, Engelhardt JF, Yan Z.
- Hum Gene Ther. 2025 May 13;36(15-16):1067-1082. doi: 10.1089/hum.2024.260.
- PMCID: PMC12409266
Park SY, et al.Hum Gene Ther. 2025.PMCID: PMC12409266 -
Novel Cystic Fibrosis Ferret Model Enables Visualization of CFTR Expression Cells and Genetic CFTR Reactivation.
- Yuan F, Sun X, Park SY, Tang Y, Feng Z, Ebadi M, Yi Y, Thompson AE, Karippaparambil JD, Engelhardt JF, Yan Z.
- Hum Gene Ther. 2025 Jan 10;36(15-16):1053-1066. doi: 10.1089/hum.2024.215.
- PMCID: PMC12419444
Yuan F, et al.Hum Gene Ther. 2025.PMCID: PMC12419444 -
Evaluation of the Toxicity and Efficacy of an Adeno-Associated Viral Vector Expressing BEST1 Delivered by Subretinal Injection in a Canine Model of Human Bestrophinopathy.
- Gray A, Kwok JC, Sato Y, Assenmacher CA, Choudhary M, Jayagopal A, Hua P, Ying GS, Swider M, Sumaroka A, Cideciyan AV, Gustavo AD, Beltran WA.
- Hum Gene Ther. Author manuscript. 2026 Jul 6;37(17-18):876-886. doi: 10.1177/10430342261458076.
- PMCID: PMC13401768
Gray A, et al.Hum Gene Ther. Author manuscript. 2026.PMCID: PMC13401768 -
Advances in Precision Editing Therapies for Alpha-1 Antitrypsin Deficiency.
- Gao J, Sontheimer E, Flotte TR, Xue W.
- Hum Gene Ther. Author manuscript. 2026 Jan 26;37(19-20):912-919. doi: 10.1177/10430342261417356.
- PMCID: PMC13372069
Gao J, et al.Hum Gene Ther. Author manuscript. 2026.PMCID: PMC13372069 -
Halting Recombinant Adeno-Associated Virus Transgene Expression Using mRNA-Lipid Nanoparticle-Delivered Meganucleases.
- Tavora R, Zhang L, Tran MH, Li H, O'Hagan D, Pan A, Barrett L, Jablonski JA, Mediouni S, Lopez A, Comella Z, Bailey C, Choe H, Farzan M, Valente ST.
- Hum Gene Ther. 2025 May 12;36(11-12):870-883. doi: 10.1089/hum.2025.011.
- PMCID: PMC12171709
Tavora R, et al.Hum Gene Ther. 2025.PMCID: PMC12171709